Sign Up to like & get
recommendations!
0
Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaf291
Abstract: Abstract Background The emergence of antibiotic-tolerant staphylococcal strains, such as vancomycin-intermediate Staphylococcus aureus (VISA), poses a significant healthcare challenge and complicates treatment regimens. VISA often exhibits mutations in Krebs cycle enzymes, promoting anaerobic metabolism under…
read more here.
Keywords:
intermediate staphylococcus;
visa;
mediated killing;
staphylococcus aureus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Microbiology"
DOI: 10.1186/s12866-020-02003-2
Abstract: Background Infections caused by drug-resistant Staphylococcus aureus , especially vancomycin-intermediate Staphylococcus aureus (VISA), leave clinicians with limited therapeutic options for treatment. Persister cells is a leading cause of recalcitrant infection and antibiotic treatment failure, and…
read more here.
Keywords:
staphylococcus aureus;
vancomycin intermediate;
aureus;
snh ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s532471
Abstract: Abstract Heterogeneous vancomycin-intermediate and vancomycin-intermediate Staphylococcus aureus (hVISA and VISA) presents significant therapeutic challenges due to high treatment failure rates and limited options. Conventional monotherapies, including daptomycin and linezolid, are often compromised by cross-resistance and…
read more here.
Keywords:
intermediate staphylococcus;
heterogeneous vancomycin;
emerging antimicrobial;
staphylococcus aureus ... See more keywords